Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes
This is a discussion on Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes within the FDA News forum, part of the Industry News and Updates category; The U.S. Food and Drug Administration (FDA) is requiring the makers of certain immunosuppressant drugs to update their labeling ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-14-2009, 12:15 PM
|
|||
|
|||
Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes
The U.S. Food and Drug Administration (FDA) is requiring the makers of certain immunosuppressant drugs to update their labeling to reflect that immunosuppressed patients are at increased risk for opportunistic infections, such as activation of latent viral infections, including BK virus-associated nephropathy.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Information for Healthcare Professionals: Cefepime (marketed as Maxipime) | industry_news | FDA News | 0 | 06-17-2009 12:00 PM |
| FDA issues Information for Healthcare Professionals for Insulin Pens | industry_news | FDA News | 0 | 03-19-2009 01:21 PM |
| Information for Healthcare Professionals Phenytoin and Fosphenytoin Sodium | industry_news | FDA News | 0 | 11-24-2008 05:31 PM |
| FDA issues an Information for Healthcare Professionals sheet for antipsychotics | industry_news | FDA News | 0 | 06-16-2008 06:05 PM |
| FDA updates information to healthcare facilities and healthcare professionals about heparin and heparin-containing medic | industry_news | FDA News | 0 | 04-25-2008 11:59 PM |
© 2008 DrugManagementForum™ powered by |
 |